Clinical Trial Update: Inflammation in Chronic Kidney Disease and Cardiovascular Disease - The Role of Genetics and Interleukin-1 Receptor Antagonist (IL-1ra) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating the role of genetics and interleukin-1 receptor antagonist (IL-1ra) in inflammation associated with chronic kidney disease …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Chronic Kidney Disease

Snippet

Sponsor: VA Office of Research and Development | Conditions: Chronic Kidney Disease, Cardiovascular Disease | Phase 2 | Status: COMPLETED | Results posted: 2016-03-17